Veronique Verge

Villejuif, 94800, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

SWI/SNF alterations define a subgroup with poorer outcome among patients with aggressive forms of adult T-cell leukemia/lymphoma.

SWI/SNF alterations define a subgroup with poorer outcome among patients with aggressive forms of adult T-cell leukemia/lymphoma.

Journal: Haematologica

Published: February 13, 2026

CAR T cell-mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis.

CAR T cell-mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis.

Journal: Science translational medicine

Published: September 24, 2025

Association of immune relevant single nucleotide polymorphisms with ALK-positive anaplastic large cell lymphoma presentation and outcome: results of the immuno ALCL study.

Association of immune relevant single nucleotide polymorphisms with ALK-positive anaplastic large cell lymphoma presentation and outcome: results of the immuno ALCL study.

Journal: Journal of translational medicine

Published: September 18, 2025

Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience.

Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience.

Journal: The journal of liquid biopsy

Published: July 01, 2024

Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study.

Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study.

Journal: Leukemia & lymphoma

Published: March 04, 2024

Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation.

Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation.

Journal: Immunotherapy

Published: March 23, 2023

Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors.

Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors.

Journal: JCO precision oncology

Published: March 02, 2023

Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study.

Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study.

Journal: American journal of hematology

Published: June 27, 2022

Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience.

Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 24, 2022

An unusual myelofibrosis.

An unusual myelofibrosis.

Journal: Blood

Published: January 24, 2022

Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma.

Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma.

Journal: Haematologica

Published: December 15, 2021

Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B-cell lymphoma: Results of LNH-EP1 study.

Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B-cell lymphoma: Results of LNH-EP1 study.

Journal: American journal of hematology

Published: April 20, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026